Abiomed (NASDAQ: ABMD) reported Q2 GAAP EPS of $0.28, which does not compare to the analyst estimate of $0.93. Revenue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE